nodes	percent_of_prediction	percent_of_DWPC	metapath
Norfloxacin—TOP2A—Etoposide—muscle cancer	0.166	0.191	CbGbCtD
Norfloxacin—SLC22A5—Dactinomycin—muscle cancer	0.155	0.179	CbGbCtD
Norfloxacin—CYP1A1—Dacarbazine—muscle cancer	0.117	0.134	CbGbCtD
Norfloxacin—TOP2A—Doxorubicin—muscle cancer	0.114	0.13	CbGbCtD
Norfloxacin—CYP1A2—Dacarbazine—muscle cancer	0.052	0.0598	CbGbCtD
Norfloxacin—CYP3A7—Vincristine—muscle cancer	0.0498	0.0572	CbGbCtD
Norfloxacin—CYP3A7-CYP3A51P—Vincristine—muscle cancer	0.0498	0.0572	CbGbCtD
Norfloxacin—CYP3A5—Vincristine—muscle cancer	0.0373	0.0429	CbGbCtD
Norfloxacin—CYP3A5—Etoposide—muscle cancer	0.0342	0.0393	CbGbCtD
Norfloxacin—SLC22A6—Methotrexate—muscle cancer	0.033	0.0379	CbGbCtD
Norfloxacin—CYP1A2—Etoposide—muscle cancer	0.0255	0.0292	CbGbCtD
Norfloxacin—CYP3A4—Vincristine—muscle cancer	0.0146	0.0167	CbGbCtD
Norfloxacin—CYP3A4—Etoposide—muscle cancer	0.0133	0.0153	CbGbCtD
Norfloxacin—CYP3A4—Doxorubicin—muscle cancer	0.0091	0.0105	CbGbCtD
Norfloxacin—TOP2A—Vindesine—Vincristine—muscle cancer	0.00148	0.236	CbGdCrCtD
Norfloxacin—TOP2A—Vinorelbine—Vincristine—muscle cancer	0.000935	0.149	CbGdCrCtD
Norfloxacin—TOP2A—Podofilox—Etoposide—muscle cancer	0.000934	0.149	CbGdCrCtD
Norfloxacin—TOP2A—Teniposide—Etoposide—muscle cancer	0.000934	0.149	CbGdCrCtD
Norfloxacin—TOP2A—Vinblastine—Vincristine—muscle cancer	0.000643	0.102	CbGdCrCtD
Norfloxacin—Erythema—Dactinomycin—muscle cancer	0.000512	0.00416	CcSEcCtD
Norfloxacin—Jaundice cholestatic—Doxorubicin—muscle cancer	0.000501	0.00407	CcSEcCtD
Norfloxacin—Neutropenia—Etoposide—muscle cancer	0.000498	0.00404	CcSEcCtD
Norfloxacin—Lacrimation increased—Doxorubicin—muscle cancer	0.000477	0.00388	CcSEcCtD
Norfloxacin—Stevens-Johnson syndrome—Etoposide—muscle cancer	0.00047	0.00382	CcSEcCtD
Norfloxacin—Acute coronary syndrome—Etoposide—muscle cancer	0.000468	0.0038	CcSEcCtD
Norfloxacin—Renal failure—Etoposide—muscle cancer	0.000466	0.00379	CcSEcCtD
Norfloxacin—Dysarthria—Doxorubicin—muscle cancer	0.000465	0.00378	CcSEcCtD
Norfloxacin—Myocardial infarction—Etoposide—muscle cancer	0.000465	0.00378	CcSEcCtD
Norfloxacin—Neuropathy peripheral—Etoposide—muscle cancer	0.000465	0.00378	CcSEcCtD
Norfloxacin—Stomatitis—Etoposide—muscle cancer	0.000462	0.00376	CcSEcCtD
Norfloxacin—Jaundice—Etoposide—muscle cancer	0.000462	0.00376	CcSEcCtD
Norfloxacin—Creatinine increased—Doxorubicin—muscle cancer	0.000462	0.00375	CcSEcCtD
Norfloxacin—Mouth ulceration—Methotrexate—muscle cancer	0.000459	0.00373	CcSEcCtD
Norfloxacin—Leukopenia—Dactinomycin—muscle cancer	0.000458	0.00372	CcSEcCtD
Norfloxacin—TOP2A—Daunorubicin—Doxorubicin—muscle cancer	0.000451	0.0718	CbGdCrCtD
Norfloxacin—TOP2A—Epirubicin—Doxorubicin—muscle cancer	0.000451	0.0718	CbGdCrCtD
Norfloxacin—TOP2A—Idarubicin—Doxorubicin—muscle cancer	0.000451	0.0718	CbGdCrCtD
Norfloxacin—Agranulocytosis—Etoposide—muscle cancer	0.000443	0.0036	CcSEcCtD
Norfloxacin—Back pain—Vincristine—muscle cancer	0.000443	0.0036	CcSEcCtD
Norfloxacin—Phosphatase alkaline increased—Doxorubicin—muscle cancer	0.00044	0.00357	CcSEcCtD
Norfloxacin—Myalgia—Dactinomycin—muscle cancer	0.000436	0.00354	CcSEcCtD
Norfloxacin—Hypoaesthesia—Etoposide—muscle cancer	0.000424	0.00344	CcSEcCtD
Norfloxacin—Agitation—Vincristine—muscle cancer	0.000421	0.00342	CcSEcCtD
Norfloxacin—Photosensitivity—Methotrexate—muscle cancer	0.00042	0.00341	CcSEcCtD
Norfloxacin—Oedema—Dactinomycin—muscle cancer	0.000418	0.0034	CcSEcCtD
Norfloxacin—Blood urea increased—Doxorubicin—muscle cancer	0.000415	0.00337	CcSEcCtD
Norfloxacin—Vertigo—Vincristine—muscle cancer	0.000411	0.00334	CcSEcCtD
Norfloxacin—Hepatic failure—Methotrexate—muscle cancer	0.00041	0.00333	CcSEcCtD
Norfloxacin—Leukopenia—Vincristine—muscle cancer	0.00041	0.00333	CcSEcCtD
Norfloxacin—Thrombocytopenia—Dactinomycin—muscle cancer	0.000409	0.00332	CcSEcCtD
Norfloxacin—Erythema multiforme—Etoposide—muscle cancer	0.000403	0.00327	CcSEcCtD
Norfloxacin—Anorexia—Dactinomycin—muscle cancer	0.000398	0.00324	CcSEcCtD
Norfloxacin—Mouth ulceration—Doxorubicin—muscle cancer	0.000398	0.00323	CcSEcCtD
Norfloxacin—Convulsion—Vincristine—muscle cancer	0.000397	0.00322	CcSEcCtD
Norfloxacin—Dermatitis exfoliative—Methotrexate—muscle cancer	0.000391	0.00317	CcSEcCtD
Norfloxacin—Myalgia—Vincristine—muscle cancer	0.00039	0.00316	CcSEcCtD
Norfloxacin—Visual disturbance—Methotrexate—muscle cancer	0.000389	0.00316	CcSEcCtD
Norfloxacin—Hypertonia—Doxorubicin—muscle cancer	0.000386	0.00313	CcSEcCtD
Norfloxacin—Chills—Etoposide—muscle cancer	0.000382	0.0031	CcSEcCtD
Norfloxacin—Anaphylactoid reaction—Methotrexate—muscle cancer	0.000381	0.00309	CcSEcCtD
Norfloxacin—Musculoskeletal discomfort—Dactinomycin—muscle cancer	0.000381	0.00309	CcSEcCtD
Norfloxacin—Oedema—Vincristine—muscle cancer	0.000373	0.00303	CcSEcCtD
Norfloxacin—Anaphylactic shock—Vincristine—muscle cancer	0.000373	0.00303	CcSEcCtD
Norfloxacin—Osteoarthritis—Methotrexate—muscle cancer	0.000369	0.00299	CcSEcCtD
Norfloxacin—Blood alkaline phosphatase increased—Doxorubicin—muscle cancer	0.000367	0.00298	CcSEcCtD
Norfloxacin—Thrombocytopenia—Vincristine—muscle cancer	0.000366	0.00297	CcSEcCtD
Norfloxacin—Photosensitivity—Doxorubicin—muscle cancer	0.000364	0.00295	CcSEcCtD
Norfloxacin—Decreased appetite—Dactinomycin—muscle cancer	0.000363	0.00295	CcSEcCtD
Norfloxacin—Dysgeusia—Etoposide—muscle cancer	0.000363	0.00295	CcSEcCtD
Norfloxacin—Hyperhidrosis—Vincristine—muscle cancer	0.000361	0.00293	CcSEcCtD
Norfloxacin—Fatigue—Dactinomycin—muscle cancer	0.00036	0.00293	CcSEcCtD
Norfloxacin—Back pain—Etoposide—muscle cancer	0.000359	0.00291	CcSEcCtD
Norfloxacin—Muscle spasms—Etoposide—muscle cancer	0.000356	0.00289	CcSEcCtD
Norfloxacin—Anorexia—Vincristine—muscle cancer	0.000356	0.00289	CcSEcCtD
Norfloxacin—Hepatic failure—Doxorubicin—muscle cancer	0.000355	0.00289	CcSEcCtD
Norfloxacin—Eye pain—Doxorubicin—muscle cancer	0.000354	0.00287	CcSEcCtD
Norfloxacin—Irritability—Methotrexate—muscle cancer	0.000352	0.00286	CcSEcCtD
Norfloxacin—Ataxia—Methotrexate—muscle cancer	0.000347	0.00282	CcSEcCtD
Norfloxacin—Feeling abnormal—Dactinomycin—muscle cancer	0.000344	0.0028	CcSEcCtD
Norfloxacin—Gastrointestinal pain—Dactinomycin—muscle cancer	0.000342	0.00278	CcSEcCtD
Norfloxacin—Liver function test abnormal—Methotrexate—muscle cancer	0.00034	0.00277	CcSEcCtD
Norfloxacin—Musculoskeletal discomfort—Vincristine—muscle cancer	0.00034	0.00276	CcSEcCtD
Norfloxacin—Dermatitis exfoliative—Doxorubicin—muscle cancer	0.000338	0.00275	CcSEcCtD
Norfloxacin—Insomnia—Vincristine—muscle cancer	0.000338	0.00274	CcSEcCtD
Norfloxacin—Paraesthesia—Vincristine—muscle cancer	0.000335	0.00272	CcSEcCtD
Norfloxacin—Dermatitis bullous—Doxorubicin—muscle cancer	0.000334	0.00271	CcSEcCtD
Norfloxacin—Vertigo—Etoposide—muscle cancer	0.000333	0.00271	CcSEcCtD
Norfloxacin—Toxic epidermal necrolysis—Methotrexate—muscle cancer	0.000332	0.0027	CcSEcCtD
Norfloxacin—Leukopenia—Etoposide—muscle cancer	0.000332	0.0027	CcSEcCtD
Norfloxacin—Abdominal pain—Dactinomycin—muscle cancer	0.00033	0.00268	CcSEcCtD
Norfloxacin—Body temperature increased—Dactinomycin—muscle cancer	0.00033	0.00268	CcSEcCtD
Norfloxacin—Anaphylactoid reaction—Doxorubicin—muscle cancer	0.00033	0.00268	CcSEcCtD
Norfloxacin—Hypoglycaemia—Doxorubicin—muscle cancer	0.000327	0.00266	CcSEcCtD
Norfloxacin—Decreased appetite—Vincristine—muscle cancer	0.000325	0.00264	CcSEcCtD
Norfloxacin—Fatigue—Vincristine—muscle cancer	0.000322	0.00262	CcSEcCtD
Norfloxacin—Convulsion—Etoposide—muscle cancer	0.000321	0.00261	CcSEcCtD
Norfloxacin—Constipation—Vincristine—muscle cancer	0.000319	0.00259	CcSEcCtD
Norfloxacin—Diplopia—Doxorubicin—muscle cancer	0.000319	0.00259	CcSEcCtD
Norfloxacin—Osteoarthritis—Doxorubicin—muscle cancer	0.000319	0.00259	CcSEcCtD
Norfloxacin—Chest pain—Etoposide—muscle cancer	0.000316	0.00256	CcSEcCtD
Norfloxacin—Eosinophilia—Methotrexate—muscle cancer	0.000316	0.00256	CcSEcCtD
Norfloxacin—Pancreatitis—Methotrexate—muscle cancer	0.000312	0.00254	CcSEcCtD
Norfloxacin—Hypersensitivity—Dactinomycin—muscle cancer	0.000308	0.0025	CcSEcCtD
Norfloxacin—Gastrointestinal pain—Vincristine—muscle cancer	0.000305	0.00248	CcSEcCtD
Norfloxacin—Confusional state—Etoposide—muscle cancer	0.000305	0.00248	CcSEcCtD
Norfloxacin—Anaphylactic shock—Etoposide—muscle cancer	0.000303	0.00246	CcSEcCtD
Norfloxacin—Ataxia—Doxorubicin—muscle cancer	0.0003	0.00244	CcSEcCtD
Norfloxacin—Asthenia—Dactinomycin—muscle cancer	0.0003	0.00244	CcSEcCtD
Norfloxacin—Blood creatinine increased—Doxorubicin—muscle cancer	0.000299	0.00243	CcSEcCtD
Norfloxacin—Neutropenia—Methotrexate—muscle cancer	0.000298	0.00242	CcSEcCtD
Norfloxacin—Thrombocytopenia—Etoposide—muscle cancer	0.000296	0.00241	CcSEcCtD
Norfloxacin—Abdominal pain—Vincristine—muscle cancer	0.000295	0.0024	CcSEcCtD
Norfloxacin—Body temperature increased—Vincristine—muscle cancer	0.000295	0.0024	CcSEcCtD
Norfloxacin—Liver function test abnormal—Doxorubicin—muscle cancer	0.000295	0.00239	CcSEcCtD
Norfloxacin—Hyperhidrosis—Etoposide—muscle cancer	0.000292	0.00238	CcSEcCtD
Norfloxacin—Orthostatic hypotension—Doxorubicin—muscle cancer	0.000292	0.00237	CcSEcCtD
Norfloxacin—Photosensitivity reaction—Methotrexate—muscle cancer	0.000291	0.00236	CcSEcCtD
Norfloxacin—Anorexia—Etoposide—muscle cancer	0.000288	0.00234	CcSEcCtD
Norfloxacin—Toxic epidermal necrolysis—Doxorubicin—muscle cancer	0.000288	0.00234	CcSEcCtD
Norfloxacin—Aspartate aminotransferase increased—Doxorubicin—muscle cancer	0.000288	0.00234	CcSEcCtD
Norfloxacin—Diarrhoea—Dactinomycin—muscle cancer	0.000286	0.00232	CcSEcCtD
Norfloxacin—Drowsiness—Methotrexate—muscle cancer	0.000284	0.00231	CcSEcCtD
Norfloxacin—Stevens-Johnson syndrome—Methotrexate—muscle cancer	0.000282	0.00229	CcSEcCtD
Norfloxacin—Renal failure—Methotrexate—muscle cancer	0.000279	0.00227	CcSEcCtD
Norfloxacin—Stomatitis—Methotrexate—muscle cancer	0.000277	0.00225	CcSEcCtD
Norfloxacin—Conjunctivitis—Methotrexate—muscle cancer	0.000276	0.00224	CcSEcCtD
Norfloxacin—Dysphagia—Doxorubicin—muscle cancer	0.000276	0.00224	CcSEcCtD
Norfloxacin—Hypersensitivity—Vincristine—muscle cancer	0.000275	0.00224	CcSEcCtD
Norfloxacin—Eosinophilia—Doxorubicin—muscle cancer	0.000273	0.00222	CcSEcCtD
Norfloxacin—Paraesthesia—Etoposide—muscle cancer	0.000272	0.00221	CcSEcCtD
Norfloxacin—Haematuria—Methotrexate—muscle cancer	0.000271	0.0022	CcSEcCtD
Norfloxacin—Pancreatitis—Doxorubicin—muscle cancer	0.000271	0.0022	CcSEcCtD
Norfloxacin—Dyspnoea—Etoposide—muscle cancer	0.00027	0.00219	CcSEcCtD
Norfloxacin—Somnolence—Etoposide—muscle cancer	0.000269	0.00218	CcSEcCtD
Norfloxacin—Asthenia—Vincristine—muscle cancer	0.000268	0.00218	CcSEcCtD
Norfloxacin—Vomiting—Dactinomycin—muscle cancer	0.000266	0.00216	CcSEcCtD
Norfloxacin—Agranulocytosis—Methotrexate—muscle cancer	0.000265	0.00215	CcSEcCtD
Norfloxacin—Rash—Dactinomycin—muscle cancer	0.000264	0.00214	CcSEcCtD
Norfloxacin—Decreased appetite—Etoposide—muscle cancer	0.000263	0.00214	CcSEcCtD
Norfloxacin—Fatigue—Etoposide—muscle cancer	0.000261	0.00212	CcSEcCtD
Norfloxacin—Constipation—Etoposide—muscle cancer	0.000259	0.0021	CcSEcCtD
Norfloxacin—Neutropenia—Doxorubicin—muscle cancer	0.000258	0.0021	CcSEcCtD
Norfloxacin—Diarrhoea—Vincristine—muscle cancer	0.000256	0.00208	CcSEcCtD
Norfloxacin—Hepatitis—Methotrexate—muscle cancer	0.000255	0.00207	CcSEcCtD
Norfloxacin—Photosensitivity reaction—Doxorubicin—muscle cancer	0.000252	0.00205	CcSEcCtD
Norfloxacin—Feeling abnormal—Etoposide—muscle cancer	0.000249	0.00203	CcSEcCtD
Norfloxacin—Nausea—Dactinomycin—muscle cancer	0.000248	0.00202	CcSEcCtD
Norfloxacin—Gastrointestinal pain—Etoposide—muscle cancer	0.000247	0.00201	CcSEcCtD
Norfloxacin—Dizziness—Vincristine—muscle cancer	0.000247	0.00201	CcSEcCtD
Norfloxacin—Drowsiness—Doxorubicin—muscle cancer	0.000246	0.002	CcSEcCtD
Norfloxacin—Visual impairment—Methotrexate—muscle cancer	0.000246	0.002	CcSEcCtD
Norfloxacin—Stevens-Johnson syndrome—Doxorubicin—muscle cancer	0.000244	0.00198	CcSEcCtD
Norfloxacin—Renal failure—Doxorubicin—muscle cancer	0.000242	0.00196	CcSEcCtD
Norfloxacin—Erythema multiforme—Methotrexate—muscle cancer	0.000241	0.00196	CcSEcCtD
Norfloxacin—Neuropathy peripheral—Doxorubicin—muscle cancer	0.000241	0.00196	CcSEcCtD
Norfloxacin—Urticaria—Etoposide—muscle cancer	0.00024	0.00195	CcSEcCtD
Norfloxacin—Jaundice—Doxorubicin—muscle cancer	0.00024	0.00195	CcSEcCtD
Norfloxacin—Stomatitis—Doxorubicin—muscle cancer	0.00024	0.00195	CcSEcCtD
Norfloxacin—Abdominal pain—Etoposide—muscle cancer	0.000239	0.00194	CcSEcCtD
Norfloxacin—Body temperature increased—Etoposide—muscle cancer	0.000239	0.00194	CcSEcCtD
Norfloxacin—Conjunctivitis—Doxorubicin—muscle cancer	0.000239	0.00194	CcSEcCtD
Norfloxacin—Tinnitus—Methotrexate—muscle cancer	0.000238	0.00193	CcSEcCtD
Norfloxacin—Vomiting—Vincristine—muscle cancer	0.000237	0.00193	CcSEcCtD
Norfloxacin—Rash—Vincristine—muscle cancer	0.000235	0.00191	CcSEcCtD
Norfloxacin—Dermatitis—Vincristine—muscle cancer	0.000235	0.00191	CcSEcCtD
Norfloxacin—Haematuria—Doxorubicin—muscle cancer	0.000235	0.00191	CcSEcCtD
Norfloxacin—Headache—Vincristine—muscle cancer	0.000234	0.0019	CcSEcCtD
Norfloxacin—Agranulocytosis—Doxorubicin—muscle cancer	0.00023	0.00186	CcSEcCtD
Norfloxacin—Chills—Methotrexate—muscle cancer	0.000229	0.00186	CcSEcCtD
Norfloxacin—Hypersensitivity—Etoposide—muscle cancer	0.000223	0.00181	CcSEcCtD
Norfloxacin—Erythema—Methotrexate—muscle cancer	0.000222	0.0018	CcSEcCtD
Norfloxacin—Nausea—Vincristine—muscle cancer	0.000222	0.0018	CcSEcCtD
Norfloxacin—Hepatitis—Doxorubicin—muscle cancer	0.000221	0.00179	CcSEcCtD
Norfloxacin—Hypoaesthesia—Doxorubicin—muscle cancer	0.00022	0.00179	CcSEcCtD
Norfloxacin—Dysgeusia—Methotrexate—muscle cancer	0.000217	0.00177	CcSEcCtD
Norfloxacin—Asthenia—Etoposide—muscle cancer	0.000217	0.00176	CcSEcCtD
Norfloxacin—Back pain—Methotrexate—muscle cancer	0.000215	0.00174	CcSEcCtD
Norfloxacin—Pruritus—Etoposide—muscle cancer	0.000214	0.00174	CcSEcCtD
Norfloxacin—Visual impairment—Doxorubicin—muscle cancer	0.000213	0.00173	CcSEcCtD
Norfloxacin—Vision blurred—Methotrexate—muscle cancer	0.000209	0.0017	CcSEcCtD
Norfloxacin—Erythema multiforme—Doxorubicin—muscle cancer	0.000209	0.0017	CcSEcCtD
Norfloxacin—Diarrhoea—Etoposide—muscle cancer	0.000207	0.00168	CcSEcCtD
Norfloxacin—Tinnitus—Doxorubicin—muscle cancer	0.000206	0.00167	CcSEcCtD
Norfloxacin—Dizziness—Etoposide—muscle cancer	0.0002	0.00163	CcSEcCtD
Norfloxacin—Vertigo—Methotrexate—muscle cancer	0.0002	0.00162	CcSEcCtD
Norfloxacin—Leukopenia—Methotrexate—muscle cancer	0.000199	0.00161	CcSEcCtD
Norfloxacin—Chills—Doxorubicin—muscle cancer	0.000198	0.00161	CcSEcCtD
Norfloxacin—Convulsion—Methotrexate—muscle cancer	0.000192	0.00156	CcSEcCtD
Norfloxacin—Vomiting—Etoposide—muscle cancer	0.000192	0.00156	CcSEcCtD
Norfloxacin—Erythema—Doxorubicin—muscle cancer	0.000192	0.00156	CcSEcCtD
Norfloxacin—Rash—Etoposide—muscle cancer	0.000191	0.00155	CcSEcCtD
Norfloxacin—Dermatitis—Etoposide—muscle cancer	0.000191	0.00155	CcSEcCtD
Norfloxacin—Headache—Etoposide—muscle cancer	0.00019	0.00154	CcSEcCtD
Norfloxacin—Flatulence—Doxorubicin—muscle cancer	0.000189	0.00154	CcSEcCtD
Norfloxacin—Chest pain—Methotrexate—muscle cancer	0.000189	0.00154	CcSEcCtD
Norfloxacin—Myalgia—Methotrexate—muscle cancer	0.000189	0.00154	CcSEcCtD
Norfloxacin—Arthralgia—Methotrexate—muscle cancer	0.000189	0.00154	CcSEcCtD
Norfloxacin—Tension—Doxorubicin—muscle cancer	0.000189	0.00153	CcSEcCtD
Norfloxacin—Dysgeusia—Doxorubicin—muscle cancer	0.000188	0.00153	CcSEcCtD
Norfloxacin—Nervousness—Doxorubicin—muscle cancer	0.000187	0.00152	CcSEcCtD
Norfloxacin—Back pain—Doxorubicin—muscle cancer	0.000186	0.00151	CcSEcCtD
Norfloxacin—Muscle spasms—Doxorubicin—muscle cancer	0.000185	0.0015	CcSEcCtD
Norfloxacin—Confusional state—Methotrexate—muscle cancer	0.000183	0.00148	CcSEcCtD
Norfloxacin—Anaphylactic shock—Methotrexate—muscle cancer	0.000181	0.00147	CcSEcCtD
Norfloxacin—Vision blurred—Doxorubicin—muscle cancer	0.000181	0.00147	CcSEcCtD
Norfloxacin—Nausea—Etoposide—muscle cancer	0.00018	0.00146	CcSEcCtD
Norfloxacin—Thrombocytopenia—Methotrexate—muscle cancer	0.000177	0.00144	CcSEcCtD
Norfloxacin—Agitation—Doxorubicin—muscle cancer	0.000177	0.00144	CcSEcCtD
Norfloxacin—Hyperhidrosis—Methotrexate—muscle cancer	0.000175	0.00142	CcSEcCtD
Norfloxacin—Vertigo—Doxorubicin—muscle cancer	0.000173	0.0014	CcSEcCtD
Norfloxacin—Anorexia—Methotrexate—muscle cancer	0.000173	0.0014	CcSEcCtD
Norfloxacin—Leukopenia—Doxorubicin—muscle cancer	0.000172	0.0014	CcSEcCtD
Norfloxacin—Palpitations—Doxorubicin—muscle cancer	0.00017	0.00138	CcSEcCtD
Norfloxacin—Convulsion—Doxorubicin—muscle cancer	0.000167	0.00135	CcSEcCtD
Norfloxacin—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.000165	0.00134	CcSEcCtD
Norfloxacin—Insomnia—Methotrexate—muscle cancer	0.000164	0.00133	CcSEcCtD
Norfloxacin—Chest pain—Doxorubicin—muscle cancer	0.000164	0.00133	CcSEcCtD
Norfloxacin—Myalgia—Doxorubicin—muscle cancer	0.000164	0.00133	CcSEcCtD
Norfloxacin—Arthralgia—Doxorubicin—muscle cancer	0.000164	0.00133	CcSEcCtD
Norfloxacin—Anxiety—Doxorubicin—muscle cancer	0.000163	0.00133	CcSEcCtD
Norfloxacin—Paraesthesia—Methotrexate—muscle cancer	0.000163	0.00132	CcSEcCtD
Norfloxacin—Dyspnoea—Methotrexate—muscle cancer	0.000162	0.00131	CcSEcCtD
Norfloxacin—Somnolence—Methotrexate—muscle cancer	0.000161	0.00131	CcSEcCtD
Norfloxacin—Dry mouth—Doxorubicin—muscle cancer	0.00016	0.0013	CcSEcCtD
Norfloxacin—Dyspepsia—Methotrexate—muscle cancer	0.00016	0.0013	CcSEcCtD
Norfloxacin—Confusional state—Doxorubicin—muscle cancer	0.000158	0.00129	CcSEcCtD
Norfloxacin—Decreased appetite—Methotrexate—muscle cancer	0.000158	0.00128	CcSEcCtD
Norfloxacin—Oedema—Doxorubicin—muscle cancer	0.000157	0.00127	CcSEcCtD
Norfloxacin—Anaphylactic shock—Doxorubicin—muscle cancer	0.000157	0.00127	CcSEcCtD
Norfloxacin—Fatigue—Methotrexate—muscle cancer	0.000156	0.00127	CcSEcCtD
Norfloxacin—Thrombocytopenia—Doxorubicin—muscle cancer	0.000154	0.00125	CcSEcCtD
Norfloxacin—Hyperhidrosis—Doxorubicin—muscle cancer	0.000152	0.00123	CcSEcCtD
Norfloxacin—Anorexia—Doxorubicin—muscle cancer	0.00015	0.00121	CcSEcCtD
Norfloxacin—Feeling abnormal—Methotrexate—muscle cancer	0.000149	0.00121	CcSEcCtD
Norfloxacin—Gastrointestinal pain—Methotrexate—muscle cancer	0.000148	0.0012	CcSEcCtD
Norfloxacin—Urticaria—Methotrexate—muscle cancer	0.000144	0.00117	CcSEcCtD
Norfloxacin—Abdominal pain—Methotrexate—muscle cancer	0.000143	0.00116	CcSEcCtD
Norfloxacin—Body temperature increased—Methotrexate—muscle cancer	0.000143	0.00116	CcSEcCtD
Norfloxacin—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.000143	0.00116	CcSEcCtD
Norfloxacin—Insomnia—Doxorubicin—muscle cancer	0.000142	0.00115	CcSEcCtD
Norfloxacin—Paraesthesia—Doxorubicin—muscle cancer	0.000141	0.00114	CcSEcCtD
Norfloxacin—Dyspnoea—Doxorubicin—muscle cancer	0.00014	0.00114	CcSEcCtD
Norfloxacin—Somnolence—Doxorubicin—muscle cancer	0.00014	0.00113	CcSEcCtD
Norfloxacin—Dyspepsia—Doxorubicin—muscle cancer	0.000138	0.00112	CcSEcCtD
Norfloxacin—Decreased appetite—Doxorubicin—muscle cancer	0.000136	0.00111	CcSEcCtD
Norfloxacin—Fatigue—Doxorubicin—muscle cancer	0.000135	0.0011	CcSEcCtD
Norfloxacin—Constipation—Doxorubicin—muscle cancer	0.000134	0.00109	CcSEcCtD
Norfloxacin—Hypersensitivity—Methotrexate—muscle cancer	0.000134	0.00108	CcSEcCtD
Norfloxacin—Asthenia—Methotrexate—muscle cancer	0.00013	0.00106	CcSEcCtD
Norfloxacin—Feeling abnormal—Doxorubicin—muscle cancer	0.000129	0.00105	CcSEcCtD
Norfloxacin—Gastrointestinal pain—Doxorubicin—muscle cancer	0.000128	0.00104	CcSEcCtD
Norfloxacin—Pruritus—Methotrexate—muscle cancer	0.000128	0.00104	CcSEcCtD
Norfloxacin—Urticaria—Doxorubicin—muscle cancer	0.000125	0.00101	CcSEcCtD
Norfloxacin—Abdominal pain—Doxorubicin—muscle cancer	0.000124	0.00101	CcSEcCtD
Norfloxacin—Body temperature increased—Doxorubicin—muscle cancer	0.000124	0.00101	CcSEcCtD
Norfloxacin—Diarrhoea—Methotrexate—muscle cancer	0.000124	0.00101	CcSEcCtD
Norfloxacin—Dizziness—Methotrexate—muscle cancer	0.00012	0.000973	CcSEcCtD
Norfloxacin—Hypersensitivity—Doxorubicin—muscle cancer	0.000116	0.000939	CcSEcCtD
Norfloxacin—Vomiting—Methotrexate—muscle cancer	0.000115	0.000936	CcSEcCtD
Norfloxacin—Rash—Methotrexate—muscle cancer	0.000114	0.000928	CcSEcCtD
Norfloxacin—Dermatitis—Methotrexate—muscle cancer	0.000114	0.000927	CcSEcCtD
Norfloxacin—Headache—Methotrexate—muscle cancer	0.000114	0.000922	CcSEcCtD
Norfloxacin—Asthenia—Doxorubicin—muscle cancer	0.000113	0.000914	CcSEcCtD
Norfloxacin—Pruritus—Doxorubicin—muscle cancer	0.000111	0.000902	CcSEcCtD
Norfloxacin—Nausea—Methotrexate—muscle cancer	0.000108	0.000874	CcSEcCtD
Norfloxacin—Diarrhoea—Doxorubicin—muscle cancer	0.000107	0.000872	CcSEcCtD
Norfloxacin—Dizziness—Doxorubicin—muscle cancer	0.000104	0.000843	CcSEcCtD
Norfloxacin—Vomiting—Doxorubicin—muscle cancer	9.98e-05	0.00081	CcSEcCtD
Norfloxacin—Rash—Doxorubicin—muscle cancer	9.89e-05	0.000804	CcSEcCtD
Norfloxacin—Dermatitis—Doxorubicin—muscle cancer	9.89e-05	0.000803	CcSEcCtD
Norfloxacin—Headache—Doxorubicin—muscle cancer	9.83e-05	0.000798	CcSEcCtD
Norfloxacin—Nausea—Doxorubicin—muscle cancer	9.32e-05	0.000757	CcSEcCtD
